GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
6

60 Degrees Pharmaceuticals SXTP · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.55

-8.19%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on 60 Degrees Pharmaceuticals

Our reporting

We have not reported on 60 Degrees Pharmaceuticals yet.

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of -0.61 a share on revenue of $270,000.

Past results

Reported against what analysts expected

14 Aug 202615 May 202626 Mar 202613 Nov 202512 Aug 20257 Apr 2025
Earnings per share-0.90-1.28-1.69-2.64-5.00-9.18
Forecast-0.73-0.76-2.28-1.84-4.96-4.77
Revenue$207,898$230,000$310,000$500,000$305,000$230,000
Forecast$185,000$435,000$320,000$200,000$320,000$250,000

Key events

  1. 20 Jan 20264-to-1 reverse split
  2. 24 Feb 20255-to-1 reverse split
  3. 12 Aug 202412-to-1 reverse split
  4. 12 Jul 2023Listed

60 Degrees Pharmaceuticals in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.